# Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment

> **NCT00977444** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Nucitec** · enrollment: 114 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** kondrium
- **DRUG:** kondrium f
- **DRUG:** methyl prednisolone (corticosteroid)

## Key facts

- **NCT ID:** NCT00977444
- **Lead sponsor:** Nucitec
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-10
- **Target enrollment:** 114 (ACTUAL)
- **Last updated:** 2010-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00977444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00977444, "Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00977444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*